Related Experiment Videos
Pharmacokinetics of antibiotics in neonates
1Department of Pediatrics, Fuji Heavy Industries Ltd Health Insurance Association, Ota General Hospital, Gunma, Japan.
Insights
Neonatal drug pharmacodynamics differ due to changing absorption, distribution, metabolism, and excretion. Dosing requires careful consideration of these factors and individual variations for safe and effective medication.
Area of Science:
- Pharmacology
- Neonatal Medicine
- Drug Metabolism
Background:
- Neonatal pharmacodynamics significantly differ from adults and children.
- Physiological immaturity in neonates impacts drug processing.
- Variations in birthweight, gestational age, and organ function are critical.
Purpose of the Study:
- To elucidate the pharmacokinetic and pharmacodynamic differences in neonates.
- To highlight the importance of physiological factors in neonatal drug dosing.
- To provide guidance on adjusting drug dosages and administration for neonates.
Main Methods:
- Review of physiological factors affecting drug disposition in neonates.
- Analysis of how immature renal and hepatic systems influence drug half-life.
- Consideration of body composition and protein binding in drug distribution.
Main Results:
- Neonates exhibit larger extracellular fluid proportions and lower plasma protein levels, affecting drug distribution.
- Immature renal and hepatic systems lead to prolonged drug half-lives.
- Individual variations in physiological parameters necessitate tailored dosing strategies.
Conclusions:
- Neonatal drug dosing must account for altered absorption, distribution, metabolism, and excretion.
- Adjusted dosing intervals, considering renal function, are crucial for neonates.
- Individualized drug therapy is essential for optimizing outcomes in neonates.
Abstract:
The pharmacodynamics in neonates are different from those in adults and children because the absorption, distribution, metabolism and excretion of drugs in neonates are always changing for the following reasons. In neonates, the proportion of extracellular fluid is large; the amount of plasma protein is small; renal function is immature; and the hepatic enzyme system is immature. In addition, individual birthweights, gestational ages in weeks, cardiopulmonary functions and renal excretory functions vary. All of these factors should be considered when selecting the dose and administration method of a drug. In concrete terms the distribution volume is large, which causes a low maximum concentration. In addition neonate renal excretory function is low and the hepatic enzyme system is immature, thus the half-life of drugs is prolonged. Therefore, the same dose per unit time as that for children (including infants) needs to be administered to neonates at dosing intervals that may be prolonged according to renal function.